The putative 5-HT3 agonist phenylbiguanide induces carrier-mediated release of [3H]dopamine.
Schmidt
C J
CJ
Merrell Dow Research Institute, Cincinnati, OH 45215.
Black
C K
CK
D000818:Animals; D001645:Biguanides / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D004337:Drug Carriers; D066298:In Vitro Techniques; D051381:Rats; D012701:Serotonin / Q000031:analogs & derivatives / Q000378:metabolism
D001645:Biguanides; D004337:Drug Carriers; D012701:Serotonin; C045918:2-methyl-5-HT; D004298:Dopamine; C008846:phenyl biguanide